Comments
FDA approves Novartis' Afinitor for kidney tumors
27.04.2012. | WASHINGTON (Reuters) - U.S. health regulators approved on Thursday Novartis AG's Afinitor for the treatment of non-cancerous kidney tumors in patients with a rare genetic disease known as tuberous sclerosis complex....
